Literature DB >> 23596273

Update of the drug resistance mutations in HIV-1: March 2013.

Victoria A Johnson1, Vincent Calvez, Huldrych F Gunthard, Roger Paredes, Deenan Pillay, Robert W Shafer, Annemarie M Wensing, Douglas D Richman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23596273      PMCID： PMC6148891     

Source DB:  PubMed          Journal:  Top Antivir Med        ISSN： 2161-5853


× No keyword cloud information.
  7 in total

Review 1.  2011 update of the drug resistance mutations in HIV-1.

Authors:  Victoria A Johnson; Vincent Calvez; Huldrych F Günthard; Roger Paredes; Deenan Pillay; Robert Shafer; Annemarie M Wensing; Douglas D Richman
Journal:  Top Antivir Med       Date:  2011-11

2.  Panel of prototypical recombinant infectious molecular clones resistant to nevirapine, efavirenz, etravirine, and rilpivirine.

Authors:  Maya Balamane; Vici Varghese; George L Melikian; W Jeffrey Fessel; David A Katzenstein; Robert W Shafer
Journal:  Antimicrob Agents Chemother       Date:  2012-06-04       Impact factor: 5.191

3.  Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus co-formulated efavirenz, emtricitabine, and tenofovir for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3 trial, analysis of results after 48 weeks.

Authors:  Paul E Sax; Edwin DeJesus; Anthony Mills; Andrew Zolopa; Calvin Cohen; David Wohl; Joel E Gallant; Hui C Liu; Lijie Zhong; Kitty Yale; Kirsten White; Brian P Kearney; Javier Szwarcberg; Erin Quirk; Andrew K Cheng
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

4.  Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel.

Authors:  Melanie A Thompson; Judith A Aberg; Jennifer F Hoy; Amalio Telenti; Constance Benson; Pedro Cahn; Joseph J Eron; Huldrych F Günthard; Scott M Hammer; Peter Reiss; Douglas D Richman; Giuliano Rizzardini; David L Thomas; Donna M Jacobsen; Paul A Volberding
Journal:  JAMA       Date:  2012-07-25       Impact factor: 56.272

5.  TMC278, a next-generation nonnucleoside reverse transcriptase inhibitor (NNRTI), active against wild-type and NNRTI-resistant HIV-1.

Authors:  Hilde Azijn; Ilse Tirry; Johan Vingerhoets; Marie-Pierre de Béthune; Guenter Kraus; Katia Boven; Dirk Jochmans; Elke Van Craenenbroeck; Gaston Picchio; Laurence T Rimsky
Journal:  Antimicrob Agents Chemother       Date:  2009-11-23       Impact factor: 5.191

6.  Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.

Authors:  Edwin DeJesus; Jürgen K Rockstroh; Keith Henry; Jean-Michel Molina; Joseph Gathe; Srinivasan Ramanathan; Xuelian Wei; Kitty Yale; Javier Szwarcberg; Kirsten White; Andrew K Cheng; Brian P Kearney
Journal:  Lancet       Date:  2012-06-30       Impact factor: 79.321

7.  Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel.

Authors:  Martin S Hirsch; Huldrych F Günthard; Jonathan M Schapiro; Françoise Brun-Vézinet; Bonaventura Clotet; Scott M Hammer; Victoria A Johnson; Daniel R Kuritzkes; John W Mellors; Deenan Pillay; Patrick G Yeni; Donna M Jacobsen; Douglas D Richman
Journal:  Clin Infect Dis       Date:  2008-07-15       Impact factor: 9.079
  7 in total
  130 in total

1.  Zidovudine as modern day salvage therapy for HIV infection.

Authors:  Katherine E Kupiec; James W Johnson; Luis F Barroso; Rebekah H Wrenn; John C Williamson
Journal:  AIDS Patient Care STDS       Date:  2014-11       Impact factor: 5.078

2.  Antiviral characteristics of GSK1265744, an HIV integrase inhibitor dosed orally or by long-acting injection.

Authors:  Tomokazu Yoshinaga; Masanori Kobayashi; Takahiro Seki; Shigeru Miki; Chiaki Wakasa-Morimoto; Akemi Suyama-Kagitani; Shinobu Kawauchi-Miki; Teruhiko Taishi; Takashi Kawasuji; Brian A Johns; Mark R Underwood; Edward P Garvey; Akihiko Sato; Tamio Fujiwara
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

Review 3.  Antiretroviral therapy: current drugs.

Authors:  Alice K Pau; Jomy M George
Journal:  Infect Dis Clin North Am       Date:  2014-09       Impact factor: 5.982

Review 4.  Recent trends in HIV-1 drug resistance.

Authors:  Janet D Siliciano; Robert F Siliciano
Journal:  Curr Opin Virol       Date:  2013-09-07       Impact factor: 7.090

5.  Differences in Evolution of HIV-1 Subtype C Reverse Transcriptase Between Children and Adults Likely Explained by Maturity of Cytotoxic T-Lymphocyte Responses.

Authors:  Shanmugam Saravanan; Selvamurthi Gomathi; Bagavathi Kausalya; Jayaseelan Boobalan; Kailapuri G Murugavel; Pachamuthu Balakrishnan; Sarvode N Mothi; Sunil S Solomon; Nagalingeswaran Kumarasamy; Poongulali Selvamuthu; Suniti Solomon; Davey M Smith
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-28       Impact factor: 2.205

6.  Timing, adherence, resistance, and ... persistence? new insight into the mechanisms of failure of HIV type 1 postexposure prophylaxis.

Authors:  Gustavo H Kijak; Jerome H Kim
Journal:  J Infect Dis       Date:  2013-09-09       Impact factor: 5.226

7.  Antiretroviral Stewardship in a Pediatric HIV Clinic: Development, Implementation and Improved Clinical Outcomes.

Authors:  Alice J Hsu; Asha Neptune; Constants Adams; Nancy Hutton; Allison L Agwu
Journal:  Pediatr Infect Dis J       Date:  2016-06       Impact factor: 2.129

8.  Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment.

Authors:  Silvia Baroncelli; Maria F Pirillo; Enrica Tamburrini; Giovanni Guaraldi; Carmela Pinnetti; Anna Degli Antoni; Clementina M Galluzzo; Chiara Stentarelli; Roberta Amici; Marco Floridia
Journal:  AIDS Res Hum Retroviruses       Date:  2015-04-08       Impact factor: 2.205

9.  Recent and Rapid Transmission of HIV Among People Who Inject Drugs in Scotland Revealed Through Phylogenetic Analysis.

Authors:  Manon Ragonnet-Cronin; Celia Jackson; Amanda Bradley-Stewart; Celia Aitken; Andrew McAuley; Norah Palmateer; Rory Gunson; David Goldberg; Catriona Milosevic; Andrew J Leigh Brown
Journal:  J Infect Dis       Date:  2018-05-25       Impact factor: 5.226

10.  HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.

Authors:  H R Lapointe; W Dong; G Q Lee; D R Bangsberg; J N Martin; A R Mocello; Y Boum; A Karakas; D Kirkby; A F Y Poon; P R Harrigan; C J Brumme
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.